316 related articles for article (PubMed ID: 17875607)
1. Correlation of posaconazole minimum fungicidal concentration and time kill test against nine Candida species.
Sóczó G; Kardos G; McNicholas PM; Balogh E; Gergely L; Varga I; Kelentey B; Majoros L
J Antimicrob Chemother; 2007 Nov; 60(5):1004-9. PubMed ID: 17875607
[TBL] [Abstract][Full Text] [Related]
2. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
Rubio Calvo MC; Gil J; Ramírez de Ocáriz I; Benito R; Rezusta A
Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462
[TBL] [Abstract][Full Text] [Related]
3. Comparison of posaconazole and voriconazole in vitro killing against Candida krusei.
Cantón E; Pemán J; Valentín A; Bosch M; Espinel-Ingroff A; Gobernado M
Diagn Microbiol Infect Dis; 2008 Oct; 62(2):177-81. PubMed ID: 18691842
[TBL] [Abstract][Full Text] [Related]
4. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
Blanco MT; Cañadas J; García-Martos P; Marín P; García-Tapia A; Rodríguez J
Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
[TBL] [Abstract][Full Text] [Related]
5. Patterns of amphotericin B killing kinetics against seven Candida species.
Cantón E; Pemán J; Gobernado M; Viudes A; Espinel-Ingroff A
Antimicrob Agents Chemother; 2004 Jul; 48(7):2477-82. PubMed ID: 15215097
[TBL] [Abstract][Full Text] [Related]
6. In vitro anticandidal activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb.
Rukayadi Y; Yong D; Hwang JK
J Antimicrob Chemother; 2006 Jun; 57(6):1231-4. PubMed ID: 16617064
[TBL] [Abstract][Full Text] [Related]
7. Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilution.
Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2011 Feb; 49(2):630-7. PubMed ID: 21159940
[TBL] [Abstract][Full Text] [Related]
8. Effect of 50% human serum on the killing activity of micafungin against eight Candida species using time-kill methodology.
Földi R; Szilágyi J; Kardos G; Berényi R; Kovács R; Majoros L
Diagn Microbiol Infect Dis; 2012 Aug; 73(4):338-42. PubMed ID: 22726529
[TBL] [Abstract][Full Text] [Related]
9. Posaconazole susceptibility testing against Candida species: comparison of broth microdilution and E-test methods.
Sóczó G; Kardos G; McNicholas PM; Falusi E; Gergely L; Majoros L
Mycoses; 2007 May; 50(3):178-82. PubMed ID: 17472612
[TBL] [Abstract][Full Text] [Related]
10. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
Espinel-Ingroff A
Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
[TBL] [Abstract][Full Text] [Related]
11. Potential fungicidal effect of voriconazole against Candida spp.
Rubio MC; de Ocáriz IR; Gil J; Benito R; Rezusta A
Int J Antimicrob Agents; 2005 Mar; 25(3):264-7. PubMed ID: 15737524
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Sensititre Yeast One microdilution method for susceptibility testing of Candida species to anidulafungin, caspofungin, and micafungin.
García-Agudo L; García-Martos P; Martos-Cañadas J; Aznar-Marín P; Marín-Casanova P; Rodríguez-Iglesias M
Rev Esp Quimioter; 2012 Dec; 25(4):256-60. PubMed ID: 23303256
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Etest method for determining posaconazole MICs for 314 clinical isolates of Candida species.
Pfaller MA; Messer SA; Mills K; Bolmström A; Jones RN
J Clin Microbiol; 2001 Nov; 39(11):3952-4. PubMed ID: 11682513
[TBL] [Abstract][Full Text] [Related]
14. Comparison of disc diffusion assay with the CLSI reference method (M27-A2) for testing in vitro posaconazole activity against common and uncommon yeasts.
Cantón E; Pemán J; Espinel-Ingroff A; Martín-Mazuelos E; Carrillo-Muñoz A; Martínez JP
J Antimicrob Chemother; 2008 Jan; 61(1):135-8. PubMed ID: 18033784
[TBL] [Abstract][Full Text] [Related]
15. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
16. Antifungal activity of posaconazole against Candida spp. and non-Candida clinical yeasts isolates.
Carrillo-Muñoz AJ; Tur-Tur C; Hernández-Molina JM; Quindós G; Marcos-Arias C; Eraso E; Cárdenes D; Ortiz-Maestro O; Santos P; Estivill D; Guardia C; Giusiano G
Rev Esp Quimioter; 2010 Sep; 23(3):122-5. PubMed ID: 20844842
[TBL] [Abstract][Full Text] [Related]
17. [In vitro activity of posaconazole against yeasts isolated in blood cultures].
Cantón E; Pemán J; Orero A; Viudes A; Gil J; Rubio MC; Gobernado M
Rev Esp Quimioter; 2002 Dec; 15(4):335-40. PubMed ID: 12587038
[TBL] [Abstract][Full Text] [Related]
18. Mycological and electron microscopic study of Solanum chrysotrichum saponin SC-2 antifungal activity on Candida species of medical significance.
Herrera-Arellano A; Martínez-Rivera Mde L; Hernández-Cruz M; López-Villegas EO; Rodríguez-Tovar AV; Alvarez L; Marquina-Bahena S; Navarro-García VM; Tortoriello J
Planta Med; 2007 Dec; 73(15):1568-73. PubMed ID: 18058612
[TBL] [Abstract][Full Text] [Related]
19. Correlation between microdilution, E-test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp.
Sims CR; Paetznick VL; Rodriguez JR; Chen E; Ostrosky-Zeichner L
J Clin Microbiol; 2006 Jun; 44(6):2105-8. PubMed ID: 16757605
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole.
Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2005 Nov; 43(11):5425-7. PubMed ID: 16272464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
